Dr. Deane Smith III, MD

Thoracic Surgery  ·  
Male
Insurances Accepted  ·  Save
Dr. Deane Smith III, MD
Dr. Deane Smith III, MD is a thoracic surgery specialist in Pittsburgh, PA and has been practicing for 13 years. He graduated from Drexel Univ Coll Of Med in 2005 and specializes in thoracic surgery.

Risks associated with the TAVR procedure include death, stroke and major bleeding

Important Risk Information for Patients

Indications:

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for relief of aortic stenosis in patients with symptomatic heart disease due to severe native calcific aortic stenosis who are judged by a Heart Team, including a cardiac surgeon, to be at intermediate or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 3% at 30 days, based on the Society of Thoracic Surgeons (STS) risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

The Edwards SAPIEN 3 transcatheter heart valve, model 9600TFX, and accessories are indicated for patients with symptomatic heart disease due to failure (stenosed, insufficient, or combined) of a surgical bioprosthetic aortic or mitral valve who are judged by a heart team, including a cardiac surgeon, to be at high or greater risk for open surgical therapy (i.e., predicted risk of surgical mortality ≥ 8% at 30 days, based on the STS risk score and other clinical co-morbidities unmeasured by the STS risk calculator).

Contraindications (Who should not use):

The Edwards SAPIEN 3 transcatheter heart valve and delivery system should not be used in patients who:

  • Cannot tolerate medications that thin the blood or prevent blood clots from forming.
  • Have an active infection in the heart or elsewhere.

Warnings:

  • There may be an increased risk of stroke in transcatheter aortic valve replacement procedures, compared to other standard treatments for aortic stenosis in the high or greater risk population.
  • If an incorrect valve size for your anatomy is used, it may lead to heart injury, valve leakage, movement, or dislodgement.
  • Patients should talk to their doctor if they have significant heart disease, a mitral valve device or are allergic to chromium, nickel, molybdenum, manganese, copper, silicon, and/or polymeric materials.
  • The SAPIEN 3 valve may not last as long in patients whose bodies do not process calcium normally.
  • During the procedure, your doctors should monitor the dye used in the body; if used in excess it could lead to kidney damage. X-ray guidance used during the procedure may cause injury to the skin, which may be painful, damaging, and long-lasting.
  • Transcatheter aortic heart valve patients should take medications that thin the blood or prevent blood clots from forming, except when likely to have an adverse reaction, as determined by their physician. The Edwards SAPIEN 3 transcatheter heart valve has not been tested for use without medications that thin the blood or prevent blood clots from forming.

Precautions:

The long-term durability of the Edwards SAPIEN 3 transcatheter heart valve is not known at this time. Regular medical follow-up is recommended to evaluate how well a patient’s heart valve is performing. Safety, performance, and durability of the SAPIEN 3 valve has not been established for placement inside a previously implanted transcatheter valve.

The safety and effectiveness of the transcatheter heart valve is also not known for patients who have:

  • An aortic heart valve that is not calcified, contains only one or two leaflets, has leaflets with large pieces of calcium that may block the vessels that supply blood to the heart or in which the main problem is that the valve leaks.
  • Previous prosthetic ring in any position.
  • Previous atrial septal occlude.
  • A heart that does not pump well, has thickening of the heart muscle, with or without blockage, unusual ultrasound images of the heart that could represent irregularities such as a blood clot, a diseased mitral valve that is calcified or leaking, or Gorlin syndrome, a condition that affects many areas of the body and increases the risk of developing various cancers and tumors.
  • Low white, red or platelet blood cell counts, or history of bleeding because the blood does not clot properly.
  • Diseased, abnormal or irregularly shaped vessels leading to the heart. Vessels which are heavily diseased or too small for associated delivery devices, or a large amount of calcification at the point of entry.
  • Allergies to blood-thinning medications or dye injected during the procedure.
  • For a valve in valve procedure, there is a risk of leakage if the previously implanted tissue valve is not securely in place or if it is damaged. There is also the possibility that a partially detached valve leaflet from the previously implanted valve could block a blood vessel.
  • Additional pre-procedure imaging will be completed to evaluate proper sizing.

Potential risks associated with the procedure include:

  • Death, stroke, paralysis (loss of muscle function), permanent disability, or severe bleeding.
  • Risks to the heart, including heart attack or heart failure, a heart that does not pump well, irregular heartbeat that may result in a need for a permanent pacemaker, chest pain, heart murmur, false aneurysm, recurring aortic stenosis(narrowing), too much fluid around the heart, injury to the structure of the heart.
  • Risks to your lungs or breathing, including difficulty breathing, fainting, buildup of fluid in or around the lungs, weakness or inability to exercise.
  • Risks involving bleeding or your blood supply, including formation of a blood clot, high or low blood pressure, limited blood supply, a decrease in red blood cells, or abnormal lab values, bleeding in the abdominal cavity, collection of blood under the skin.
  • Additional risks, including life-threatening infection, dislodgement of calcified material, air embolism (air bubbles in the blood vessels), poor kidney function or failure, nerve injury, fever, allergic reaction to anesthesia or dye, reoperation, pain, infection or bleeding at incision sites, or swelling.

Additional potential risks specifically associated with the use of the heart valve include:

  • Valve movement after deployment, blockage or disruption of blood flow through the heart, need for additional heart surgery and possible removal of the SAPIEN 3 valve, a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), nonstructural valve dysfunction (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage, etc.) or mechanical failure of the delivery system and/or accessories.

CAUTION: Federal (United States) law restricts these devices to sale by or on the order of a physician.

Edwards, Edwards Lifesciences, the stylized E logo, Edwards SAPIEN, Edwards SAPIEN 3, SAPIEN, and SAPIEN 3 are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

© 2017 Edwards Lifesciences Corporation. All rights reserved. PP--US-2507 v1.0

Edwards Lifesciences One Edwards Way, Irvine CA 92614 USA edwards.com

320 E North Ave

Pittsburgh, PA 15212

Contact Information

(412) 359-3551

Dr. Deane Smith III, MD

Dr. Deane Smith III, MD

Accepted insurance

  • Aetna
  • Blue Cross Blue Shield
  • Blue Cross Blue Shield of Louisiana
  • Blue Cross Blue Shield of Massachusetts
  • Capital District Physician's Health Plan (CDPHP)
  • Cigna
  • EmblemHealth
  • Empire Blue Cross Blue Shield
  • HealthFirst
  • MultiPlan
  • Tricare

*Please verify this information when scheduling an appointment.

Learn about Dr. Smith III

Be confident in your decisions by checking out your provider's top areas of care, education, patient reviews and more. Learn about finding the right doctor for you.

Top Care Areas

See how frequently Dr. Smith III performs your care needs compared to other doctors.

Vascular Disease
normal
more than 48% of peers
Heart Disease
normal
more than 44% of peers
Coronary Artery Disease (CAD)
normal
more than 43% of peers

Dr. Smith III's percentages are based on the rate of treatment compared to peers nationwide from insurance data. Learn more info about our data and this Top Care Areas component.

1  Specialties

  • Thoracic Surgery

0  Board Certifications

Dr. Smith III does not have any board certifications listed.

32  Conditions Treated

  • Aneurysm
  • Angina and Acute Coronary Syndrome
  • Aortic Aneurysm
  • Aortic Dissection
  • Aortic Stenosis
  • Aortic Valve Disease
  • Aortic Valve Regurgitation
  • Arrhythmias
  • Atrial Fibrillation
  • Atrial Flutter
  • Benign Tumor
  • Cancer
  • Cardiomegaly
  • Cardiomyopathy
  • Carotid Artery Disease
  • Congenital Heart Defects
  • Congenital Heart Disease
  • Coronary Artery Disease (CAD)
  • Endocarditis
  • Heart Disease
  • Lung Cancer
  • Lung Neoplasms, Not Specified as Malignant
  • Mitral Valve Disease
  • Mitral Valve Regurgitation
  • Pericardial Disease
  • Peripheral Arterial Aneurysm
  • Peripheral Arterial Aneurysm and Dissection
  • Pulmonary Disease
  • Pulmonary Embolism
  • Septal Defect
  • Thrombosis
  • Vascular Disease
Less
Read Less

28  Procedures

Background Check

Malpractice Claims not available

Healthgrades does not collect malpractice information for Pennsylvania.

0 Sanctions

No sanctions history found for the years that Healthgrades collects data.

0 Board Actions

No board actions found for the years that Healthgrades collects data.

Education

  • Drexel Univ Coll Of Med
    Medical School | Graduated 2005

Awards & Recognition

Awards & Honors

Dr. Smith III has no awards or honors listed.

Media & Publications

Dr. Smith III has no media or publications listed.

Languages Spoken

  • English

Memberships & Professional Affiliations

Dr. Smith III does not have any memberships or affiliations listed. If you are Dr. Smith III and would like to add memberships or affiliations, please update your profile.

Dr. Smith III's Reviews

Help millions of people find the right doctor. Share your experience today!
Likelihood of recommending Dr. Smith III to family and friends
Image of Dr. Smith III
Are you Dr. Smith III?
Make it easy for patients to share their feedback. Also manage your personalized profile!

Visit Dr. Smith III

Dr. Smith III accepts 11 insurance carriers

  • Aetna
    Aetna HMO
    Choice Plus POS II
  • Blue Cross Blue Shield
    Blue Card PPO
  • Blue Cross Blue Shield of Louisiana
    BlueConnect HMO
  • Blue Cross Blue Shield of Massachusetts
    Preferred Blue PPO
  • Capital District Physician's Health Plan (CDPHP)
    Capital District Physician's Health Plan (CDPHP) HMO
  • Cigna
    Cigna HMO
    Cigna PPO
    Open Access Plus
  • EmblemHealth
    Health Insurance Plan of Greater New York (HIP) PPO
  • Empire Blue Cross Blue Shield
    Empire Blue Cross Blue Shield HMO
  • HealthFirst
    ABCD HMO
  • MultiPlan
    MultiPlan PPO
    PHCS Network PPO
  • Tricare
Less
Read Less

*Please verify this information when scheduling an appointment.

Dr. Smith III's affiliated hospitals

Bellevue Hospital Center
462 1st Ave
New York, NY 10016
View hospital profile
NYU Langone Medical Center
550 1st Ave
New York, NY 10016
View hospital profile

Nearby doctors with similar experience

Cardiothoracic Surgery
(1)
Cardiac Surgery
(4)
General Surgery
(21)
Thoracic Surgery
(2)
Thoracic Surgery
(2)
Thoracic Surgery
(4)
Cardiac Surgery
(8)
Thoracic Surgery
(14)